Alkylating agents.
Berger
N A
NA
Department of Medicine, Ireland Cancer Center, University Hospital of Cleveland, Case Western Reserve University, OH.
D000477:Alkylating Agents / Q000009:adverse effects / Q000627:therapeutic use*; D017322:Clinical Trials, Phase II as Topic; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D008171:Lung Diseases / Q000139:chemically induced
D000477:Alkylating Agents; D007155:Immunologic Factors